Clinical and Genetic Characterization of Individuals With Achromatopsia

Completed

Conditions studied: Achromatopsia

In brief

The purpose of this study is to identify individuals with achromatopsia caused by mutations in the CNGB3 gene and characterize their clinical condition using several tests of visual function every 6 months for up to 1.5 years.

Key facts

Study ID
NCT01846052
Run by
Beacon Therapeutics
People needed
56
Starts
2013-06-01
Expected to finish
2017-04-01
Last updated by the study team
2017-10-13

Who can join

Age: 6 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.